Martin Edgardo Rojano-Rodriguez
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Martin Edgardo Rojano-Rodriguez has a total of 29 co-authors. Here are the top co-authors by number of shared publications:
- Pablo Maravilla
Hospital General Dr. Manuel Gea González, Mexico City 14080, Mexico
2 shared publications A. González Angulo-Rocha
Servicio de Endoscopia Gastrointestinal, Hospital General Dr. Manuel Gea González, México D.F., México
1 shared publication- Adolfo Cuendis-Velázquez
División de Cirugía General y Endoscópica, Hospital General Dr. Manuel Gea González, México D.F., México
1 shared publication - Adolfo José Chávez-Negrete
Director of Education and Research in Health, Hospital of Specialties at XXI Century National Medical Center, IMSS, Cuauhtémoc 330, Colonia Doctores, 02070, Mexico City, Mexico
1 shared publication - Aldo Torre
Gastroenterology Department ABC Medical Center Mexico City Mexico
1 shared publication - Angélica Olivo-Díaz
Departamento de Biologia Molecular e Histocompatibilidad, Hospital General “Dr. Manuel Gea Gonzalez”, Mexico City 14080, Mexico
1 shared publication
Latest Publications
- 11 January 2021
- Published by Springer Nature in Digestive Diseases and Sciences
- Vol. 66 (12) , 4501-4507
Hepamet Fibrosis Score in Nonalcoholic Fatty Liver Disease Patients in Mexico: Lower than Expected Positive Predictive Value
Background Nonalcoholic fatty liver disease (NAFLD) has been associated with different negative outcomes in the presence of advanced fibrosis. The Hepamet Fibrosis Score (HFS), a recently described noninvasive score, has shown excellent performance for the detection of advanced fibrosis. The aim of this study was to assess its performance in a Mexican population with NAFLD. Methods This was a retrospective cross-sectional study performed in 222 patients with biopsy-proven NAFLD, of whom 33(14%) had advanced fibrosis. We retrieved clinical data from each patient’s medical record to compute the HFS, the NAFLD Fibrosis Score (NFS), and the Fibrosis-4 (FIB-4), and assess their performance. Results When considering the models as continuous variables, the area under the receiving operating characteristics curve of the HFS(0.758) was not different from that of the NFS(0.669, p = 0.09) or FIB-4(0.796, p = 0.1). The HFS had a sensitivity, specificity, positive and negative predictive values of 76.7% (95% CI 57.7–90.1), 90.1% (95% CI 85–93.9), 36.7% (95% CI 19.9–56.1), and 94.3% (95% CI 88.5–97.7), respectively. Indeterminate results (i.e., gray area) were more common with FIB-4 and HFS when compared with NFS [139(63%) and 122(55%) vs 80(36%), p < 0.001]. The variables that were associated with misclassification using the HFS were diabetes [OR 3.40 (95% CI 1.42–8.10), p = 0.006] and age [OR 1.06 (95% CI 1.01–1.11), p = 0.01]. Conclusion The HFS showed sensitivity and specificity similar to that reported in the original publication; however, the positive predictive value was 36.7% at a pretest probability of 14%. The role of the HFS in prospective studies and in combination with other methods should be further explored.
- 11 January 2021
- Published by Springer Nature in Digestive Diseases and Sciences
- Vol. 66 (12) , 4501-4507
Hepamet Fibrosis Score in Nonalcoholic Fatty Liver Disease Patients in Mexico: Lower than Expected Positive Predictive Value
Background Nonalcoholic fatty liver disease (NAFLD) has been associated with different negative outcomes in the presence of advanced fibrosis. The Hepamet Fibrosis Score (HFS), a recently described noninvasive score, has shown excellent performance for the detection of advanced fibrosis. The aim of this study was to assess its performance in a Mexican population with NAFLD. Methods This was a retrospective cross-sectional study performed in 222 patients with biopsy-proven NAFLD, of whom 33(14%) had advanced fibrosis. We retrieved clinical data from each patient’s medical record to compute the HFS, the NAFLD Fibrosis Score (NFS), and the Fibrosis-4 (FIB-4), and assess their performance. Results When considering the models as continuous variables, the area under the receiving operating characteristics curve of the HFS(0.758) was not different from that of the NFS(0.669, p = 0.09) or FIB-4(0.796, p = 0.1). The HFS had a sensitivity, specificity, positive and negative predictive values of 76.7% (95% CI 57.7–90.1), 90.1% (95% CI 85–93.9), 36.7% (95% CI 19.9–56.1), and 94.3% (95% CI 88.5–97.7), respectively. Indeterminate results (i.e., gray area) were more common with FIB-4 and HFS when compared with NFS [139(63%) and 122(55%) vs 80(36%), p < 0.001]. The variables that were associated with misclassification using the HFS were diabetes [OR 3.40 (95% CI 1.42–8.10), p = 0.006] and age [OR 1.06 (95% CI 1.01–1.11), p = 0.01]. Conclusion The HFS showed sensitivity and specificity similar to that reported in the original publication; however, the positive predictive value was 36.7% at a pretest probability of 14%. The role of the HFS in prospective studies and in combination with other methods should be further explored.
- 12 September 2019
- Published by Springer Nature in Obesity Surgery
- Vol. 30 (1) , 102-110
The Short-Term Effects of Roux-en-Y Gastric Bypass on Renal Excretion of Sodium and Its Association with Blood Pressure
Bariatric surgery has been shown to be effective in reducing weight and has benefits, such as lowering blood pressure. An increase in urinary sodium excretion has been suggested as a possible mechanism. This study explored changes in sodium excretion and their correlation with blood pressure after Roux-en-Y gastric bypass.
- 12 September 2019
- Published by Springer Nature in Obesity Surgery
- Vol. 30 (1) , 102-110
The Short-Term Effects of Roux-en-Y Gastric Bypass on Renal Excretion of Sodium and Its Association with Blood Pressure
Bariatric surgery has been shown to be effective in reducing weight and has benefits, such as lowering blood pressure. An increase in urinary sodium excretion has been suggested as a possible mechanism. This study explored changes in sodium excretion and their correlation with blood pressure after Roux-en-Y gastric bypass.
- Open Access
- 22 February 2016
- Published by Springer Nature in Hereditas
- Vol. 153 (1) , 2
Leptin receptor gene polymorphisms and morbid obesity in Mexican patients
Human obesity is due to a complex interaction among environmental, behavioral, developmental and genetic factors, including the interaction of leptin (LEP) and leptin receptor (LEPR). Several LEPR mutations and polymorphisms have been described in patients with early onset severe obesity and hyperphagic eating behavior; however, some contradictory findings have also been reported. In the present study we explored the association of six LEPR gene polymorphisms in patients with morbid obesity. Twenty eight patients with morbid obesity and 56 non-obese Mexican Mestizo individuals were included. Typing of rs1137100, rs1137101, rs1805134, Ser492Thr, rs1805094 and rs1805096 LEPR polymorphisms was performed by PCR and allele specific hybridization. The LEPR Ser492Thr polymorphism was monomorphic with the presence of only the Ser492Thr-G allele. Allele C and genotype T/C for rs1805134 polymorphism were associated with susceptibility to morbid obesity (p = 0.02 and p = 0.03, respectively). No association was observed with any haplotype. Linkage disequilibrium (LD) showed that five polymorphisms (rs1137100, rs1137101, rs1805134, rs1805094 and rs1805096) were in absolute (D’ = 1) but none in perfect (r2 = 1) LD. Our results suggest that rs1805134 polymorphism could be involved in the development of morbid obesity, whilst none of the alleles of the LEPR gene, rs1137100, rs1137101, rs1805094 and rs1805096 were associated as risk factors. However, more studies are necessary to confirm or reject this hypothesis.
- 22 February 2016
- Published by Springer Nature in Hereditas
- Vol. 153 (1) , 2
Open AccessLeptin receptor gene polymorphisms and morbid obesity in Mexican patients
Human obesity is due to a complex interaction among environmental, behavioral, developmental and genetic factors, including the interaction of leptin (LEP) and leptin receptor (LEPR). Several LEPR mutations and polymorphisms have been described in patients with early onset severe obesity and hyperphagic eating behavior; however, some contradictory findings have also been reported. In the present study we explored the association of six LEPR gene polymorphisms in patients with morbid obesity. Twenty eight patients with morbid obesity and 56 non-obese Mexican Mestizo individuals were included. Typing of rs1137100, rs1137101, rs1805134, Ser492Thr, rs1805094 and rs1805096 LEPR polymorphisms was performed by PCR and allele specific hybridization. The LEPR Ser492Thr polymorphism was monomorphic with the presence of only the Ser492Thr-G allele. Allele C and genotype T/C for rs1805134 polymorphism were associated with susceptibility to morbid obesity (p = 0.02 and p = 0.03, respectively). No association was observed with any haplotype. Linkage disequilibrium (LD) showed that five polymorphisms (rs1137100, rs1137101, rs1805134, rs1805094 and rs1805096) were in absolute (D’ = 1) but none in perfect (r2 = 1) LD. Our results suggest that rs1805134 polymorphism could be involved in the development of morbid obesity, whilst none of the alleles of the LEPR gene, rs1137100, rs1137101, rs1805094 and rs1805096 were associated as risk factors. However, more studies are necessary to confirm or reject this hypothesis.
- Open Access
- 1 January 2014
- Published by Elsevier in Revista de Gastroenterología de México
- Vol. 79 (1) , 22-27
Utilidad de la coledocoscopia transquirúrgica en el tratamiento de litos biliares difíciles
- 1 January 2014
- Published by Elsevier in Revista de Gastroenterología de México
- Vol. 79 (1) , 22-27
Open AccessUtilidad de la coledocoscopia transquirúrgica en el tratamiento de litos biliares difíciles